Stéphanie Cloutier

Champagne PA, Bourassa M, Desjardins MP, Cloutier S, Demers C, Singbo NU, Néron H, Pelland-Marcotte MC

Post-procedural bleeding rate and haemostatic treatment use for dental procedures before and after the implementation of a standardized protocol for people with inherited bleeding disorders

Haemophilia, 28 (5), 2022.

Résumé | Liens:

Dubé E, Merlen C, Bonnefoy A, Gauthier J, Castilloux JF, Charlebois J, Cloutier S, Demers C, Sabapathy CA, St-Louis J, Vézina C, Warner M, Rivard GÉ

Evaluation of anti-factor VIII antibodies in haemophilia A subjects switching products following a provincial tender

Haemophilia, 28 (1), 2022.

| Liens:

Stimec J, Dover S, Pullenayegum E, Blanchette VS, Doria AS, Feldman BM, Carcao M, Rivard GE, Israels SJ, Chan AK, Steele M, Cloutier S, Klaassen RJ, Price VE, Sinha R, Laferriere N, Paradis E, Wu JKM, Babyn P

Magnetic resonance imaging in boys with severe hemophilia A: Serial and end-of-study findings from the Canadian Hemophilia Primary Prophylaxis Study

Res Pract Thromb Haemost, 5 (7), 2021.

Résumé | Liens:

Cheng J, Hashem MA, Barabé F, Cloutier S, Xi L, Raffeld M, Pittaluga S, Jaffe ES

CCND1 Genomic Rearrangement as a Secondary Event in High Grade B-Cell Lymphoma

Hemasphere, 5 (1), 2021.

| Liens:

Dubé E, Merlen C, Bonnefoy A, Gauthier J, Castilloux JF, Cloutier S, Demers C, Sabapathy CA, St-Louis J, Vézina C, Warner M, Rivard GÉ

A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma)

Haemophilia, 27 (4), 2021.

| Liens:

Dover S, Blanchette VS, Wrathall D, Pullenayegum E, Kazandjian D, Song B, Hawes SA, Cloutier S, Rivard GE, Klaassen RJ, Paradis E, Laferriere N, Stain AM, Chan AK, Israels SJ, Sinha R, Steele M, Wu JKM, Feldman BM

Hemophilia prophylaxis adherence and bleeding using a tailored, frequency-escalated approach: The Canadian Hemophilia Primary Prophylaxis Study

Res Pract Thromb Haemost, 4 (2), 2020.

Résumé | Liens:

Greenblatt M, Cloutier S, Lemelin V

Portal vein thrombosis in a patient known for congenital afibrinogenemia

Haemophilia, 26 (6), 2020.

| Liens:

Vincent G, Richebourg S, Cloutier S, Fortin M, Jacob S, Amin-Hashem M

Large B-Cell Lymphoma With IRF4 Rearrangement: From Theory to Practice

AJSP Rev Rep, 24 (5), 2019.

| Liens:

Mizrahi T, Doyon K, Dube E, Bonnefoy A, Warner M, Cloutier S, Demers C, Castilloux JF, Rivard GE, St-Louis J

Relapse pattern and long-term outcomes in subjects with acquired haemophilia A

Haemophilia, 25 (2), 2019.

Résumé | Liens:

Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon MC, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS

Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort

Lancet Haematol, 5 (6), 2018.

Résumé | Liens: